中国麻风皮肤病杂志 ›› 2022, Vol. 38 ›› Issue (12): 918-923.doi: 10.12144/zgmfskin202212918

• 综述 • 上一篇    下一篇

毛发红糠疹的治疗进展

朱慧英,杨宝琦   

  1. 山东第一医科大学附属皮肤病医院（山东省皮肤病医院），山东省皮肤病性病防治研究所，济南，250022
  • 出版日期:2022-12-15 发布日期:2022-10-27

Update of the treatment of pityriasis rubra pilaris

ZHU Huiying, YANG Baoqi   

  1. Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250022, China
  • Online:2022-12-15 Published:2022-10-27

PDF (PC)

135

摘要： 毛发红糠疹病因及发病机制不明，通常对传统治疗抵抗。由于缺乏高质量的证据，目前尚无治疗指南，维A酸类药物被普遍作为一线治疗，近年来生物制剂被证明在严重难治性病例中有快速、显著的疗效。本文就PRP治疗方法进行综述。

关键词: 毛发红糠疹, 维A酸类药物, 生物制剂

Abstract: The etiology and pathogenesis of pityriasis rubra pilaris remains unclear, and it is often resistant to conventional treatment. Due to the lack of high-quality evidence, there are currently no treatment guidelines. Retinoids are considered as first-line therapy, and in recent years biologics have been shown to have rapid and significant responses in severe refractory cases. The treatments of pityriasis rubra pilaris are reviewed.

Key words: pityriasis rubra pilaris, retinoids, biologics